<DOC>
	<DOCNO>NCT01431807</DOCNO>
	<brief_summary>To evaluate safety efficacy long-term treatment SYR-472 diabetic patient .</brief_summary>
	<brief_title>Long-term Study SYR-472</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Hypoglycemic Agents</mesh_term>
	<criteria>1 . The participant outpatient . 2 . The participant sign date write , informed consent form require privacy authorization prior initiation study procedure . 3 . Diabetes Mellitus 1 . The participant serious cardiac disease , serious cerebrovascular disorder , serious pancreatic hematological disease . 2 . The participant consider ineligible study reason investigator subinvestigator .</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2016</verification_date>
</DOC>